This site is intended for US health care professionals only.
A new law will expand access to non-opioids for outpatient surgeries. Are you ready? Sign up for NOPAIN Act updates now.
14+ Million Patients And Counting
This site is intended to provide medical and product information to health care professionals in the United States.
To report an adverse event, email drugsafety@pacira.com or call 1-855-793-9727.
For medical inquiries related to EXPAREL, submit a request to Medical Information or call 1-855-793-9727.
These are not all of the potential important safety considerations for EXPAREL; please see the full Prescribing Information.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.
Please refer to full Prescribing Information.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.
Important Safety Information
Reimbursement in the ASC & HOPD for Medicare Patients
Reimbursement for EXPAREL in outpatient settings beginning January 1, 2025
THE NOPAIN ACT is a federal mandate that requires Medicare to reimburse for non-opioids, like EXPAREL, used during all surgeries conducted in the ambulatory surgery center (ASC) or hospital outpatient department (HOPD) setting.
This will expand Medicare reimbursement beyond the ambulatory surgery center, where EXPAREL already has reimbursement via code C9290.
Keep me informed about the NOPAIN Act
Select the option that best describes you:
This site is intended for US residents. Non-US residents click here.